Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression
Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays importa...
Saved in:
| Published in | PloS one Vol. 3; no. 3; p. e1784 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
12.03.2008
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats.
Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats.
These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. |
|---|---|
| AbstractList | Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. Background Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Methods and Findings Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. Conclusion These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. Background Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Methods and Findings Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. Conclusion These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats.BACKGROUNDCurrent theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats.Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats.METHODS AND FINDINGSSprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats.These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders.CONCLUSIONThese findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders. |
| Audience | Academic |
| Author | Pillai, Anilkumar |
| AuthorAffiliation | Department of Psychiatry and Health Behavior, Medical College of Georgia, Medical Research Service Line, Veterans Affairs Medical Center, Augusta, Georgia, United States of America Chiba University, Japan |
| AuthorAffiliation_xml | – name: Chiba University, Japan – name: Department of Psychiatry and Health Behavior, Medical College of Georgia, Medical Research Service Line, Veterans Affairs Medical Center, Augusta, Georgia, United States of America |
| Author_xml | – sequence: 1 givenname: Anilkumar surname: Pillai fullname: Pillai, Anilkumar |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18335055$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11v0zAUhiM0xD7gHyCIhDSJixZ_JHayi0ldu0GliSEK3FqOc9J4SuNgO7DxK_jJOGs3tRNCXMU6ft732CevD6O91rQQRS8xGmPK8btr09tWNuMulMcIIcyz5El0gHNKRowgure13o8OnbtGKKUZY8-ifZxRmqI0PYh-z0BZkA7K-Pyms-CcNm1sqnjRWdP7WxLrNvY1xDNjnWmkByub-JOFyprWh-XUWA83A7VQtf5lutpCq2Us2zI-012Q2HimnbEl2JN4MvAWgs_Q5qf2dXw2-3ix1ft59LSSjYMXm-9R9PXi_Mv0w-jy6v18OrkcKcaIH-W8SiipiqoqgENWEIUJytOCg-IpwxnOVFmAVEUlIZOyRHnFMM_zRKaMlDmmR9HrtW_XGCc2w3QCU0xIxnPMAzFfE6WR16KzeiXtrTBSi7uCsUshrdeqAYFTVhKKcY4zSCiQjHCcIlBSIUJZVQav0023vlhBqaD1YY47prs7ra7F0vwQhDAS3IPB8cbAmu89OC9W2iloGtmC6Z3giOaEpiSAbx6Bf7_beE0tZTi-bisTuobjyhJWWoVEVTrUJwknLOVZSoPg7Y4gMOG3-6XsnRPzxef_Z6--7bLHW2wNsvF1yFk_5MPtgq-2J_gwuvsoB-BkDShrnAsBFUr7u5yFq-lGYCSGd3M_DjG8G7F5N0GcPBI_-P9L9ge10R7w |
| CitedBy_id | crossref_primary_10_1016_j_neubiorev_2009_01_004 crossref_primary_10_1038_tp_2014_26 crossref_primary_10_1093_hmg_ddv231 crossref_primary_10_1016_j_neubiorev_2021_10_009 crossref_primary_10_1016_j_pnpbp_2020_110052 crossref_primary_10_1038_mp_2012_37 crossref_primary_10_1111_and_14153 crossref_primary_10_1016_j_bj_2020_01_001 crossref_primary_10_1016_j_lfs_2015_02_010 crossref_primary_10_1093_schbul_sbaa161 crossref_primary_10_1002_ajmg_b_31087 crossref_primary_10_1038_npp_2011_96 crossref_primary_10_1038_tpj_2013_6 crossref_primary_10_3389_fpsyt_2023_1054506 crossref_primary_10_1016_j_pmip_2016_11_003 crossref_primary_10_3390_ijerph20032111 crossref_primary_10_1016_j_psc_2012_06_006 crossref_primary_10_3390_genes14020243 crossref_primary_10_1124_mol_109_055848 crossref_primary_10_3390_ijms252011204 crossref_primary_10_1016_j_bj_2016_08_001 crossref_primary_10_1097_YIC_0b013e328338bc5a crossref_primary_10_1007_s00210_025_03912_7 crossref_primary_10_2217_pgs_13_51 crossref_primary_10_3390_ijms252011043 crossref_primary_10_1016_j_nbd_2010_04_017 |
| Cites_doi | 10.1523/JNEUROSCI.4035-04.2005 10.1016/S0092-8674(00)00114-8 10.1007/BF02245608 10.1083/jcb.152.5.1087 10.1001/archpsyc.60.5.443 10.1007/BF02245602 10.1016/j.schres.2004.08.004 10.1038/sj.npp.1300039 10.1016/S0165-1781(02)00127-0 10.1126/stke.2003.207.pe49 10.1016/j.biopsych.2004.07.008 10.1016/S0920-9964(00)00084-0 10.1093/emboj/cdf493 10.1016/0166-2236(94)90138-4 10.1007/BF02245612 10.1126/science.1095862 10.1007/s00213-002-1230-z 10.1016/j.brainres.2005.11.047 10.1038/sj.mp.4000718 10.1016/S0079-6123(04)47023-X 10.1007/s00213-005-0191-4 10.1038/nn1258 10.1016/S0074-7742(04)59011-6 10.1038/sj.npp.1301074 10.1038/nrm1400 10.1016/j.pneurobio.2005.06.003 10.1074/jbc.M108368200 10.1097/00019052-199604000-00012 10.1016/S0920-9964(00)00081-5 10.1006/mcne.1997.0641 10.1016/j.conb.2004.04.001 10.1080/14734220410029164 10.1016/j.jpsychires.2006.01.005 10.1046/j.1471-4159.2003.01851.x 10.1016/S0074-7742(04)59003-7 10.1038/sj.mp.4001308 10.1038/sj.mp.4001678 10.1016/j.psychres.2003.11.006 10.1073/pnas.081071198 10.1016/j.euroneuro.2004.12.005 10.1038/sj.mp.4001081 10.1016/j.biopsych.2004.12.002 10.1111/j.1440-1819.2004.01229.x 10.1074/jbc.C100386200 10.1093/hmg/ddl244 10.1128/MCB.18.4.1946 10.1016/j.schres.2004.02.016 10.1006/bbrc.1998.9964 10.1016/S0278-5846(03)00112-X 10.1074/jbc.M108234200 10.1016/j.neulet.2003.08.004 10.1086/342734 10.1152/ajplung.00372.2001 10.1016/j.schres.2006.12.026 10.1371/journal.pmed.0020263 10.1038/sj.cdd.4402188 10.1016/j.neulet.2004.08.045 10.1038/35081514 10.1016/0014-2999(95)00242-D 10.1016/S0165-0173(99)00031-4 10.1002/jcp.21078 10.1016/j.schres.2005.11.021 10.1016/j.schres.2007.01.025 10.1017/S1461145700001759 10.1016/j.tcb.2005.11.004 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2008 Public Library of Science 2008 Pillai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Pillai. 2008 |
| Copyright_xml | – notice: COPYRIGHT 2008 Public Library of Science – notice: 2008 Pillai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Pillai. 2008 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0001784 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints in Context Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medicine (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Sprouty2 in Schizophrenia |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1312287917 oai_doaj_org_article_156d2311918e43e2827150ecac0236fd PMC2262156 2900684681 A472657853 18335055 10_1371_journal_pone_0001784 |
| Genre | Journal Article |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY CGR CUY CVF ECM EIF NPM PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 5PM PUEGO AAPBV ABPTK ESTFP |
| ID | FETCH-LOGICAL-c662t-97f432fbffbe7e8b2c12095b7ec7561818cdbeacbfae8aad09f617994a562d913 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Nov 05 00:20:57 EDT 2023 Wed Aug 27 01:23:16 EDT 2025 Thu Aug 21 18:13:18 EDT 2025 Fri Jul 11 07:45:26 EDT 2025 Fri Jul 25 11:45:24 EDT 2025 Tue Jun 10 21:31:20 EDT 2025 Fri Jun 27 03:58:31 EDT 2025 Fri Jun 27 04:02:19 EDT 2025 Thu May 22 20:58:01 EDT 2025 Thu Apr 03 06:58:21 EDT 2025 Tue Jul 01 03:30:51 EDT 2025 Thu Apr 24 23:05:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c662t-97f432fbffbe7e8b2c12095b7ec7561818cdbeacbfae8aad09f617994a562d913 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: AP. Performed the experiments: AP. Analyzed the data: AP. Contributed reagents/materials/analysis tools: AP. Wrote the paper: AP. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0001784 |
| PMID | 18335055 |
| PQID | 1312287917 |
| PQPubID | 1436336 |
| PageCount | e1784 |
| ParticipantIDs | plos_journals_1312287917 doaj_primary_oai_doaj_org_article_156d2311918e43e2827150ecac0236fd pubmedcentral_primary_oai_pubmedcentral_nih_gov_2262156 proquest_miscellaneous_70392352 proquest_journals_1312287917 gale_infotracacademiconefile_A472657853 gale_incontextgauss_ISR_A472657853 gale_incontextgauss_IOV_A472657853 gale_healthsolutions_A472657853 pubmed_primary_18335055 crossref_citationtrail_10_1371_journal_pone_0001784 crossref_primary_10_1371_journal_pone_0001784 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-03-12 |
| PublicationDateYYYYMMDD | 2008-03-12 |
| PublicationDate_xml | – month: 03 year: 2008 text: 2008-03-12 day: 12 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2008 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | I Gross (ref31) 2001; 276 RW Grillo (ref18) 2007; 4 A Pillai (ref37) 2007 F Angelucci (ref22) 2000; 3 FP Bymaster (ref62) 1996; 124 GV Michailov (ref46) 2004; 304 PF Buckley (ref21) 2007; 91 E Shimizu (ref19) 2003; 351 W Green (ref38) 2006; 1070 H Stefansson (ref43) 2002; 71 AV Terry Jr (ref66) 2002; 164 SL Eastwood (ref2) 2004; 59 M Didriksen (ref61) 1995; 28 BJ Kinon (ref64) 1996; 124 J Schlessinger (ref51) 2000; 103 W Ding (ref40) 2007; 212 M Takahashi (ref15) 2000; 5 HK Manji (ref41) 2003; 2003 P Yusoff (ref53) 2002; 277 YL Tan (ref17) 2005; 74 I Gross (ref26) 2007; 14 A Sasaki (ref33) 2001; 276 HJ Kim (ref25) 2004; 5 WE Bunney (ref27) 2000; 31 RJ Rylett (ref4) 1994; 17 S Iritani (ref14) 2003; 27 JD Sweatt (ref52) 2004; 14 L Pozzi (ref59) 2003; 86 JM Mason (ref24) 2006; 16 SE Arnold (ref3) 2005; 147 JL Merchant (ref35) 1999; 254 MC Jockers-Scherübl (ref20) 2004; 371 T Futamura (ref48) 2002; 7 B Xu (ref28) 2005; 2 K Hashimoto (ref49) 2005; 135 J Xing (ref34) 1998; 18 KL Davis (ref47) 2003; 60 CS Weickert (ref10) 2003; 8 CS Weickert (ref11) 2005; 10 CR Bramham (ref7) 2005; 76 D Tefft (ref54) 2002; 283 T Pizzorusso (ref6) 1996; 9 A Pillai (ref23) 2006; 82 G Corfas (ref44) 2004; 7 ES Wong (ref55) 2002; 21 M Kodama (ref39) 2004; 56 T Durany (ref13) 2001; 52 DG Winder (ref42) 2001; 2 D Ben-Shachar (ref1) 2004; 59 Y Hakak (ref45) 2001; 98 T Hashimoto (ref12) 2005; 25 BH Yang (ref58) 2004; 58 V De Luca (ref29) 2005; 183 LF Jarskog (ref36) 2007; 32 AV Terry Jr (ref65) 2003; 28 T Skarsfeldt (ref63) 1996; 124 G Shoval (ref8) 2005; 15 A Cellerino (ref5) 1997; 9 R Hashimoto (ref50) 2006; 15 EF Torrey (ref60) 2001; 49 PF Buckley (ref9) 2007; 94 MA Impagnatiello (ref32) 2001; 152 K Toyooka (ref16) 2002; 110 SV Kyosseva (ref56) 2004; 3 HT Mueller (ref30) 2004; 71 JL Browning (ref57) 2005; 57 15006484 - Int Rev Neurobiol. 2004;59:47-72 15194111 - Curr Opin Neurobiol. 2004 Jun;14(3):311-7 16442781 - Schizophr Res. 2006 Feb 15;82(1):95-106 16099088 - Prog Neurobiol. 2005 Jun;76(2):99-125 11698404 - J Biol Chem. 2002 Feb 1;277(5):3195-201 10889532 - Mol Psychiatry. 2000 May;5(3):293-300 12742865 - Arch Gen Psychiatry. 2003 May;60(5):443-56 8935803 - Psychopharmacology (Berl). 1996 Mar;124(1-2):87-94 8935807 - Psychopharmacology (Berl). 1996 Mar;124(1-2):126-33 15722005 - Schizophr Res. 2005 May 1;74(2-3):263-70 16405875 - Brain Res. 2006 Jan 27;1070(1):242-5 11433371 - Nat Rev Neurosci. 2001 Jul;2(7):461-74 8935797 - Psychopharmacology (Berl). 1996 Mar;124(1-2):2-34 16240163 - Psychopharmacology (Berl). 2005 Dec;183(3):378-82 15233576 - Cerebellum. 2004;3(2):94-9 8521906 - Eur J Pharmacol. 1995 Aug 15;281(3):241-50 7531891 - Trends Neurosci. 1994 Nov;17(11):486-90 16546213 - J Psychiatr Res. 2007 Jan-Feb;41(1-2):31-5 10719142 - Brain Res Brain Res Rev. 2000 Mar;31(2-3):138-46 9918860 - Biochem Biophys Res Commun. 1999 Jan 19;254(2):454-61 11057895 - Cell. 2000 Oct 13;103(2):211-25 11585837 - J Biol Chem. 2001 Dec 7;276(49):46460-8 16146415 - PLoS Med. 2005 Oct;2(10):e263 12225946 - Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L700-6 11343574 - Int J Neuropsychopharmacol. 2000 Mar;3(1):13-25 15162166 - Nat Neurosci. 2004 Jun;7(6):575-80 15476686 - Biol Psychiatry. 2004 Oct 15;56(8):570-80 15581715 - Prog Brain Res. 2005;147:319-45 15474907 - Schizophr Res. 2004 Dec 1;71(2-3):361-70 14583394 - Neurosci Lett. 2003 Nov 13;351(2):111-4 11296301 - Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51 12145742 - Am J Hum Genet. 2002 Oct;71(4):877-92 17599098 - Cell Death Differ. 2007 Oct;14(10):1802-12 12851636 - Mol Psychiatry. 2003 Jun;8(6):592-610 11495895 - J Biol Chem. 2001 Sep 28;276(39):36804-8 12921913 - Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):801-7 9528766 - Mol Cell Biol. 1998 Apr;18(4):1946-55 15500971 - Neurosci Lett. 2004 Nov 16;371(1):79-83 15173823 - Nat Rev Mol Cell Biol. 2004 Jun;5(6):441-50 12589383 - Neuropsychopharmacology. 2003 Feb;28(2):300-9 16641945 - Neuropsychopharmacology. 2007 Jan;32(1):95-102 15006492 - Int Rev Neurobiol. 2004;59:273-96 9361277 - Mol Cell Neurosci. 1997;9(5-6):397-408 12192610 - Mol Psychiatry. 2002;7(7):673-82 12457265 - Psychopharmacology (Berl). 2002 Dec;164(4):360-8 12127475 - Psychiatry Res. 2002 Jul 31;110(3):249-57 17805306 - Neuropsychopharmacology. 2008 Jul;33(8):1942-51 11238463 - J Cell Biol. 2001 Mar 5;152(5):1087-98 17306505 - Schizophr Res. 2007 Mar;91(1-3):1-5 17524622 - Schizophr Res. 2007 Aug;94(1-3):1-11 11356590 - Schizophr Res. 2001 Apr 30;49(3):295-9 15780848 - Biol Psychiatry. 2005 Mar 15;57(6):617-23 16959794 - Hum Mol Genet. 2006 Oct 15;15(20):3024-33 15940304 - Mol Psychiatry. 2005 Jul;10(7):637-50 15044753 - Science. 2004 Apr 30;304(5671):700-3 15149291 - Psychiatry Clin Neurosci. 2004 Jun;58(3):262-7 8782980 - Curr Opin Neurol. 1996 Apr;9(2):122-5 12871586 - J Neurochem. 2003 Jul;86(2):451-9 15993491 - Psychiatry Res. 2005 Jun 30;135(3):257-60 15647480 - J Neurosci. 2005 Jan 12;25(2):372-83 17516543 - J Cell Physiol. 2007 Sep;212(3):796-806 11595394 - Schizophr Res. 2001 Oct 1;52(1-2):79-86 15820422 - Eur Neuropsychopharmacol. 2005 May;15(3):319-29 16337795 - Trends Cell Biol. 2006 Jan;16(1):45-54 14600293 - Sci STKE. 2003 Nov 4;2003(207):pe49 12234920 - EMBO J. 2002 Sep 16;21(18):4796-808 |
| References_xml | – volume: 25 start-page: 372 year: 2005 ident: ref12 article-title: Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4035-04.2005 – volume: 103 start-page: 211 year: 2000 ident: ref51 article-title: Cell signaling by receptor tyrosine kinases. publication-title: Cell doi: 10.1016/S0092-8674(00)00114-8 – volume: 124 start-page: 87 year: 1996 ident: ref62 article-title: Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, a1-adrenergic and muscarinic receptors in vivo in rats. publication-title: Psychopharmacology (Berl.) doi: 10.1007/BF02245608 – year: 2007 ident: ref37 article-title: Erythropoietin Prevents Haloperidol Treatment-Induced Neuronal Apoptosis through Regulation of BDNF. publication-title: Neuropsychopharmacology Sep 5 – volume: 152 start-page: 1087 year: 2001 ident: ref32 article-title: Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. publication-title: J Cell Biol doi: 10.1083/jcb.152.5.1087 – volume: 60 start-page: 443 year: 2003 ident: ref47 article-title: White matter changes in schizophrenia: evidence for myelin-related dysfunction. publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.60.5.443 – volume: 124 start-page: 2 year: 1996 ident: ref64 article-title: Mechanisms of action of atypical antipsychotic drugs: a critical analysis. publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02245602 – volume: 74 start-page: 263 year: 2005 ident: ref17 article-title: Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. publication-title: Schizophr Res doi: 10.1016/j.schres.2004.08.004 – volume: 28 start-page: 300 year: 2003 ident: ref65 article-title: Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300039 – volume: 110 start-page: 249 year: 2002 ident: ref16 article-title: Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. publication-title: Psychiatry Res doi: 10.1016/S0165-1781(02)00127-0 – volume: 2003 start-page: pe49 year: 2003 ident: ref41 article-title: Signal transduction and genes-to-behaviors pathways in psychiatric diseases. publication-title: Sci STKE doi: 10.1126/stke.2003.207.pe49 – volume: 56 start-page: 570 year: 2004 ident: ref39 article-title: Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.07.008 – volume: 52 start-page: 79 year: 2001 ident: ref13 article-title: Brain derived neurotrophic factor and neurotrophin-3 in schizophrenic psychoses. publication-title: Schizophrenia Res doi: 10.1016/S0920-9964(00)00084-0 – volume: 21 start-page: 4796 year: 2002 ident: ref55 article-title: Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. publication-title: EMBO J doi: 10.1093/emboj/cdf493 – volume: 17 start-page: 486 year: 1994 ident: ref4 article-title: Role of neurotrophins in cholinergic-neuron function in the adult and aged CNS. publication-title: Trends Neurosci doi: 10.1016/0166-2236(94)90138-4 – volume: 124 start-page: 126 year: 1996 ident: ref63 article-title: Differential effect of antipsychotics on place navigation of rats in Morris water maze. A comparative study between novel and reference antipsychotics. publication-title: Psychopharmacology (Berl.) doi: 10.1007/BF02245612 – volume: 304 start-page: 700 year: 2004 ident: ref46 article-title: Axonal neuregulin-1 regulates myelin sheath thickness. publication-title: Science doi: 10.1126/science.1095862 – volume: 164 start-page: 360 year: 2002 ident: ref66 article-title: Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-002-1230-z – volume: 1070 start-page: 242 year: 2006 ident: ref38 article-title: Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex. publication-title: Brain Res doi: 10.1016/j.brainres.2005.11.047 – volume: 5 start-page: 293 year: 2000 ident: ref15 article-title: Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000718 – volume: 147 start-page: 319 year: 2005 ident: ref3 article-title: Neurodevelopment, neuroplasticity, and new genes for schizophrenia. publication-title: Prog Brain Res doi: 10.1016/S0079-6123(04)47023-X – volume: 183 start-page: 378 year: 2005 ident: ref29 article-title: Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-005-0191-4 – volume: 7 start-page: 575 year: 2004 ident: ref44 article-title: Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. publication-title: Nat Neurosci doi: 10.1038/nn1258 – volume: 59 start-page: 273 year: 2004 ident: ref1 article-title: Mitochondria, synaptic plasticity, and schizophrenia. publication-title: Int Rev Neurobiol doi: 10.1016/S0074-7742(04)59011-6 – volume: 32 start-page: 95 year: 2007 ident: ref36 article-title: Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301074 – volume: 5 start-page: 441 year: 2004 ident: ref25 article-title: Modulation of signalling by Sprouty: a developing story. publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm1400 – volume: 76 start-page: 99 year: 2005 ident: ref7 article-title: BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2005.06.003 – volume: 277 start-page: 3195 year: 2002 ident: ref53 article-title: Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. publication-title: J Biol Chem doi: 10.1074/jbc.M108368200 – volume: 9 start-page: 122 year: 1996 ident: ref6 article-title: Plasticity in the developing visual system. publication-title: Curr Opin Neurol doi: 10.1097/00019052-199604000-00012 – volume: 49 start-page: 295 year: 2001 ident: ref60 article-title: Risk factors and confounders in the geographical clustering of schizophrenia. publication-title: Schizophr Res doi: 10.1016/S0920-9964(00)00081-5 – volume: 9 start-page: 397 year: 1997 ident: ref5 article-title: Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. publication-title: Mol Cell Neurosci doi: 10.1006/mcne.1997.0641 – volume: 14 start-page: 311 year: 2004 ident: ref52 article-title: Mitogen-activated protein kinases in synaptic plasticity and memory. publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2004.04.001 – volume: 3 start-page: 94 year: 2004 ident: ref56 article-title: The role of the extracellular signal-regulated kinase pathway in cerebellar abnormalities in schizophrenia. publication-title: Cerebellum doi: 10.1080/14734220410029164 – volume: 4 start-page: 31 year: 2007 ident: ref18 article-title: Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2006.01.005 – volume: 86 start-page: 451 year: 2003 ident: ref59 article-title: Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. publication-title: J Neurochem doi: 10.1046/j.1471-4159.2003.01851.x – volume: 59 start-page: 47 year: 2004 ident: ref2 article-title: The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? publication-title: Int Rev Neurobiol doi: 10.1016/S0074-7742(04)59003-7 – volume: 8 start-page: 592 year: 2003 ident: ref10 article-title: Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001308 – volume: 10 start-page: 637 year: 2005 ident: ref11 article-title: Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001678 – volume: 135 start-page: 257 year: 2005 ident: ref49 article-title: No changes in serum epidermal growth factor levels in patients with schizophrenia. publication-title: Psychiatry Res doi: 10.1016/j.psychres.2003.11.006 – volume: 98 start-page: 4746 year: 2001 ident: ref45 article-title: Genome-wide expression analysis reveals dysregulation of myelination-relatedgenes in chronic schizophrenia. publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.081071198 – volume: 15 start-page: 319 year: 2005 ident: ref8 article-title: The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. publication-title: Eur Neuropsychopharmacol doi: 10.1016/j.euroneuro.2004.12.005 – volume: 7 start-page: 673 year: 2002 ident: ref48 article-title: Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001081 – volume: 57 start-page: 617 year: 2005 ident: ref57 article-title: Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions. publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2004.12.002 – volume: 58 start-page: 262 year: 2004 ident: ref58 article-title: Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration. publication-title: Psychiatry Clin Neurosci doi: 10.1111/j.1440-1819.2004.01229.x – volume: 276 start-page: 36804 year: 2001 ident: ref33 article-title: Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. publication-title: J Biol Chem doi: 10.1074/jbc.C100386200 – volume: 15 start-page: 3024 year: 2006 ident: ref50 article-title: Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. publication-title: Hum Mol Genet doi: 10.1093/hmg/ddl244 – volume: 18 start-page: 1946 year: 1998 ident: ref34 article-title: Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. publication-title: Mol Cell Biol doi: 10.1128/MCB.18.4.1946 – volume: 71 start-page: 361 year: 2004 ident: ref30 article-title: NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. publication-title: Schizophr Res doi: 10.1016/j.schres.2004.02.016 – volume: 254 start-page: 454 year: 1999 ident: ref35 article-title: Sp1 phosphorylation by Erk 2 stimulates DNA binding. publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1998.9964 – volume: 27 start-page: 801 year: 2003 ident: ref14 article-title: Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. publication-title: Progress in Neuro-Psychopharmacology and Biological Psychiatry doi: 10.1016/S0278-5846(03)00112-X – volume: 276 start-page: 46460 year: 2001 ident: ref31 article-title: Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. publication-title: J Biol Chem doi: 10.1074/jbc.M108234200 – volume: 351 start-page: 111 year: 2003 ident: ref19 article-title: Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. publication-title: Neurosci Lett doi: 10.1016/j.neulet.2003.08.004 – volume: 71 start-page: 877 year: 2002 ident: ref43 article-title: Neuregulin 1 and susceptibility to schizophrenia. publication-title: Am J Hum Genet. doi: 10.1086/342734 – volume: 283 start-page: L700 year: 2002 ident: ref54 article-title: mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins. publication-title: Am J Physiol Lung Cell Mol Physiol. doi: 10.1152/ajplung.00372.2001 – volume: 91 start-page: 1 year: 2007 ident: ref21 article-title: Brain derived neurotrophic factor in first-episode psychosis. publication-title: Schizophr Res doi: 10.1016/j.schres.2006.12.026 – volume: 2 start-page: e263 year: 2005 ident: ref28 article-title: Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. publication-title: PLoS Med doi: 10.1371/journal.pmed.0020263 – volume: 14 start-page: 1802 year: 2007 ident: ref26 article-title: Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4402188 – volume: 371 start-page: 79 year: 2004 ident: ref20 article-title: Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.08.045 – volume: 2 start-page: 461 year: 2001 ident: ref42 article-title: Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. publication-title: Nat Rev Neurosci doi: 10.1038/35081514 – volume: 28 start-page: 241 year: 1995 ident: ref61 article-title: Effects of antipsychotics on cognitive behavior in rats using the delayed non-match to position paradigm. publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(95)00242-D – volume: 31 start-page: 138 year: 2000 ident: ref27 article-title: Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(99)00031-4 – volume: 212 start-page: 796 year: 2007 ident: ref40 article-title: Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. publication-title: J Cell Physiol doi: 10.1002/jcp.21078 – volume: 82 start-page: 95 year: 2006 ident: ref23 article-title: Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. publication-title: Schizophr Res doi: 10.1016/j.schres.2005.11.021 – volume: 94 start-page: 1 year: 2007 ident: ref9 article-title: Neurotrophins and schizophrenia. publication-title: Schizophr Res doi: 10.1016/j.schres.2007.01.025 – volume: 3 start-page: 13 year: 2000 ident: ref22 article-title: Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145700001759 – volume: 16 start-page: 45 year: 2006 ident: ref24 article-title: Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2005.11.004 – reference: 15780848 - Biol Psychiatry. 2005 Mar 15;57(6):617-23 – reference: 16337795 - Trends Cell Biol. 2006 Jan;16(1):45-54 – reference: 15162166 - Nat Neurosci. 2004 Jun;7(6):575-80 – reference: 9918860 - Biochem Biophys Res Commun. 1999 Jan 19;254(2):454-61 – reference: 17524622 - Schizophr Res. 2007 Aug;94(1-3):1-11 – reference: 11495895 - J Biol Chem. 2001 Sep 28;276(39):36804-8 – reference: 8935807 - Psychopharmacology (Berl). 1996 Mar;124(1-2):126-33 – reference: 12145742 - Am J Hum Genet. 2002 Oct;71(4):877-92 – reference: 11356590 - Schizophr Res. 2001 Apr 30;49(3):295-9 – reference: 15474907 - Schizophr Res. 2004 Dec 1;71(2-3):361-70 – reference: 15722005 - Schizophr Res. 2005 May 1;74(2-3):263-70 – reference: 12234920 - EMBO J. 2002 Sep 16;21(18):4796-808 – reference: 15006492 - Int Rev Neurobiol. 2004;59:273-96 – reference: 12921913 - Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):801-7 – reference: 16240163 - Psychopharmacology (Berl). 2005 Dec;183(3):378-82 – reference: 12871586 - J Neurochem. 2003 Jul;86(2):451-9 – reference: 8935803 - Psychopharmacology (Berl). 1996 Mar;124(1-2):87-94 – reference: 14583394 - Neurosci Lett. 2003 Nov 13;351(2):111-4 – reference: 12851636 - Mol Psychiatry. 2003 Jun;8(6):592-610 – reference: 8782980 - Curr Opin Neurol. 1996 Apr;9(2):122-5 – reference: 15173823 - Nat Rev Mol Cell Biol. 2004 Jun;5(6):441-50 – reference: 14600293 - Sci STKE. 2003 Nov 4;2003(207):pe49 – reference: 15044753 - Science. 2004 Apr 30;304(5671):700-3 – reference: 9528766 - Mol Cell Biol. 1998 Apr;18(4):1946-55 – reference: 12457265 - Psychopharmacology (Berl). 2002 Dec;164(4):360-8 – reference: 11238463 - J Cell Biol. 2001 Mar 5;152(5):1087-98 – reference: 12742865 - Arch Gen Psychiatry. 2003 May;60(5):443-56 – reference: 11433371 - Nat Rev Neurosci. 2001 Jul;2(7):461-74 – reference: 8521906 - Eur J Pharmacol. 1995 Aug 15;281(3):241-50 – reference: 7531891 - Trends Neurosci. 1994 Nov;17(11):486-90 – reference: 10719142 - Brain Res Brain Res Rev. 2000 Mar;31(2-3):138-46 – reference: 15993491 - Psychiatry Res. 2005 Jun 30;135(3):257-60 – reference: 16405875 - Brain Res. 2006 Jan 27;1070(1):242-5 – reference: 17516543 - J Cell Physiol. 2007 Sep;212(3):796-806 – reference: 16442781 - Schizophr Res. 2006 Feb 15;82(1):95-106 – reference: 15149291 - Psychiatry Clin Neurosci. 2004 Jun;58(3):262-7 – reference: 15940304 - Mol Psychiatry. 2005 Jul;10(7):637-50 – reference: 11585837 - J Biol Chem. 2001 Dec 7;276(49):46460-8 – reference: 16959794 - Hum Mol Genet. 2006 Oct 15;15(20):3024-33 – reference: 15476686 - Biol Psychiatry. 2004 Oct 15;56(8):570-80 – reference: 16146415 - PLoS Med. 2005 Oct;2(10):e263 – reference: 10889532 - Mol Psychiatry. 2000 May;5(3):293-300 – reference: 15581715 - Prog Brain Res. 2005;147:319-45 – reference: 12127475 - Psychiatry Res. 2002 Jul 31;110(3):249-57 – reference: 11296301 - Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51 – reference: 9361277 - Mol Cell Neurosci. 1997;9(5-6):397-408 – reference: 17599098 - Cell Death Differ. 2007 Oct;14(10):1802-12 – reference: 15194111 - Curr Opin Neurobiol. 2004 Jun;14(3):311-7 – reference: 17805306 - Neuropsychopharmacology. 2008 Jul;33(8):1942-51 – reference: 16099088 - Prog Neurobiol. 2005 Jun;76(2):99-125 – reference: 17306505 - Schizophr Res. 2007 Mar;91(1-3):1-5 – reference: 12192610 - Mol Psychiatry. 2002;7(7):673-82 – reference: 16641945 - Neuropsychopharmacology. 2007 Jan;32(1):95-102 – reference: 12589383 - Neuropsychopharmacology. 2003 Feb;28(2):300-9 – reference: 15500971 - Neurosci Lett. 2004 Nov 16;371(1):79-83 – reference: 11698404 - J Biol Chem. 2002 Feb 1;277(5):3195-201 – reference: 11595394 - Schizophr Res. 2001 Oct 1;52(1-2):79-86 – reference: 15006484 - Int Rev Neurobiol. 2004;59:47-72 – reference: 12225946 - Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L700-6 – reference: 11057895 - Cell. 2000 Oct 13;103(2):211-25 – reference: 11343574 - Int J Neuropsychopharmacol. 2000 Mar;3(1):13-25 – reference: 15820422 - Eur Neuropsychopharmacol. 2005 May;15(3):319-29 – reference: 15233576 - Cerebellum. 2004;3(2):94-9 – reference: 15647480 - J Neurosci. 2005 Jan 12;25(2):372-83 – reference: 16546213 - J Psychiatr Res. 2007 Jan-Feb;41(1-2):31-5 – reference: 8935797 - Psychopharmacology (Berl). 1996 Mar;124(1-2):2-34 |
| SSID | ssj0053866 |
| Score | 2.034326 |
| Snippet | Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed... Background Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration,... BACKGROUND: Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration,... Background Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration,... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1784 |
| SubjectTerms | Abnormalities Analysis Animals Antipsychotic Agents - therapeutic use Antipsychotics Base Sequence Bipolar disorder Bipolar Disorder - drug therapy Bipolar Disorder - metabolism Brain Brain-derived neurotrophic factor Brain-Derived Neurotrophic Factor - genetics Brain-Derived Neurotrophic Factor - metabolism Cellular signal transduction Correlation Cortex (frontal) DNA Primers Drugs Functional plasticity Gene expression Genes Haloperidol Humans Intracellular Signaling Peptides and Proteins - genetics Intracellular Signaling Peptides and Proteins - metabolism Kinases Male Membrane Proteins Mental disorders Mental Health/Mood Disorders Mental Health/Neuropsychiatric Disorders Mental Health/Psychopharmacology Mental Health/Schizophrenia and Other Psychoses Myelination Neural plasticity Neuroplasticity Neuroscience/Cognitive Neuroscience Neuroscience/Neurodevelopment Olanzapine Prefrontal cortex Prefrontal Cortex - metabolism Psychotropic drugs Rats Regulatory mechanisms (biology) Reverse Transcriptase Polymerase Chain Reaction Ribonucleic acid RNA RNA, Messenger - genetics Rodents Schizophrenia Schizophrenia - drug therapy Schizophrenia - metabolism Signal transduction Synaptic plasticity |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQn3hBjF8LDGZNSMBDtiZ27Ia3ja0aSAyJMbQ3y47tUalKqqWVxn_Bn8xd7IYGTRoPvEXxVYnvzufvmrvPhLzWWeYkxN40czlPueXj1Fgh0op7b1khKtkd0_n5TJxe8E-XxeXGUV9YExbogYPiDiC_sIBBIK2YOM4cZAgSMIyrdIXc595i9IU9b51MhRgMq1iI2CjHZHYQ7bK_aGq333HETPhgI-r4-vuoPFrMm_Y2yPl35eTGVjR9SB5EDEkPw7tvkXuufkS24ipt6dtIJf3uMfl13KHC1lnqbmLJa00bT8_hoavlz5zOagoQkNoGz83W2I48pyDokdcALiusxb1BqXazOo_q2lIzW2BeTG0k8HxPNcpfx_I6in_x0qPjs-nGs5-Qi-nJtw-naTyDIa2EyJdpKT1nuTfeG7DpxOQVNtsWRrpKAvSC7b6yBoK38dpNtLbj0gskmeMagJUtM_aUjGrQ-jahfMJY2bH9cMjBSquZMUhOw7X1pZMsIWxtEFVFgnI8J2Ouuq9uEhKVoF-FZlTRjAlJ-18tAkHHHfJHaOteFum1uxvgdCo6nbrL6RKyi56iQq9qHyTUIZe5QPogmMxeJ4EUGzXW8FzpVduqj1--_4PQ-deB0Jso5BtQB7xD6JuAOSF110ByGx13Pe0WlJDlkBFDRp6QnbUz3z682w9DeMFvRrp2zapVsCFAClDkCXkWPP-PkrFdb1wUCZGDNTHQ7HCknv3oCMwB8gPSFM__hylekPuhhIelWb5DRsvrlXsJOHFpXnUh4TfRsmj3 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELagvPCCGL8WGMxCSMBDtiZ2nIQX1K4rA4mBKEN7i5zYHpWqJDStNP4L_mTuHKdr0AS8VfVFiX32-Tv77jtCXsgg0DHYXj_QIfe54kM_V0L4BTdGsUgUsS3T-fFUnJzxD-fRuTtwa1xYZWcTraFWVYFn5IcBC0JA9-BdvK1_-Fg1Cm9XXQmNm-RWADsNhnQl03edJYa1LIRLl2NxcOi0c1BXpT6wTDEJ721HlrV_Y5sH9aJqrgOef8ZPbm1I07vkjkOSdNSqfofc0OU9suPWakNfOULp1_fJr4nFho1W9PjSBb6WtDJ0Bi9dr36GdF5SAIJ0UmH1bIlJyQv6GT4W2Q3g5xFG5F6i1Gw7Ro_KUtHxvEbvmHY0nm_oCOWXLsiO4kEvHU9Op1vvfkDOpsdfj058V4nBL4QIV34aG85CkxuTg2aTPCww5TbKY13EAMBg0y9UDiY8N1InUqphagRSzXEJ8EqlAXtIBiWM-i6hPGEstZw_HDyxVEmW50hRw6UyqY6ZR1inkKxwNOVYLWOR2bu3GNyVdnwzVGPm1OgRf_NU3dJ0_EN-jLreyCLJtv2jWl5kbs1m4NoqgL_g0SaaMw3OaQzwWReyQNp9ozyyjzMlazNWN6YiG_E4FEgiBJ15biWQaKPESJ4LuW6a7P2nb_8hNPvSE3rphEwFwwHf0GZPQJ-QwKsnuYsTt-t2k12tHI_sdZP5-ub9TTMYGbw5kqWu1k0G2wI4AlHokUftzL8aZEzaG0aRR-LemuiNbL-lnH-3NOYA_AFvisd__6gn5HYbosP8INwjg9VyrZ8CDlzlz-xi_w0XlWBZ priority: 102 providerName: ProQuest |
| Title | Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/18335055 https://www.proquest.com/docview/1312287917 https://www.proquest.com/docview/70392352 https://pubmed.ncbi.nlm.nih.gov/PMC2262156 https://doaj.org/article/156d2311918e43e2827150ecac0236fd http://dx.doi.org/10.1371/journal.pone.0001784 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaxugshAQ8pGoSJ06QEOonA2llWinaW5QPe1SqktK0Uvdf8Cdz5zihQeXjJarqs2Lf2ee7-O53hLyMLEtw0L2mJWxmspR1zTj1PDNhUqaO6yVclem8nHgXM_bpxr05IFXNVs3AYq9rh_WkZqtFZ_v97j1s-HeqagO3qk6dZZ6JjkKA8dkhOYKziWNNg0tW3yvA7vY8nUD3p56NA0rh-NfaurVc5MU-U_T3iMqdI2r8gNzXtiXtlYvhmByI7CE51ru3oK81xPSbR-THUFmLhUjpaKtDYTOaSzqFl27WdzadZxRMQzrMsZ52hGnKC3oFg0W8A_g5wBjdLVJNd6P2aJSltD9fIlNpBez5lvaQfqXD7ih--qX94WS88-7HZDYefRlcmLo2g5l4nr02Ay6ZY8tYyhhk7cd2gkm4bsxFwsEkAzMgSWNQ6rGMhB9FaTeQHoLPsQgMrjSwnCeklQHXTwhlvuMECgWIgW8WpJETxwhaw6JUBoI7BnEqgYSJBi7H-hmLUN3GcXBgSv6GKMZQi9EgZt1rWQJ3_IO-j7KuaRF2W_2Rr25DvYtDcHZTMIjBx_UFcwS4qxwMapFECQLxy9Qg57hSwjKHtVYeYY9x20NYIZjMC0WB0BsZxvbcRpuiCD9-_vofRNPrBtErTSRzYAeMocyngDkhpFeD8gQXbjXtAphg2eApg6dukLNqMe9vPq-bQe3gXVKUiXxThHBQgGvg2gZ5Wq78X0zGNL6u6xqEN_ZEg7PNlmz-TQGbgysAFqh3-vdBPSP3yqAdx7TsM9JarzbiOViG67hNDvkNh6c_sPA5_tAmR_3R5Oq6rb61tJUy-AlwLWtS |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGeYAXtPFvYYNaCAQ8ZGsSJ2mREGrXlZZtBdFt2ptxYntUqpLStGL7FnwSPiN3idM1aAJe9lbV18b2ne9PfPc7Ql4Ix1Eh6F7bUS6zmWQNO5JBYMdMa-n5QRzmbTqPhkH_hH0888_WyK-yFgbTKkudmCtqmcb4jnzX8RwXvHuILt5Pv9vYNQpvV8sWGoVYHKjLHxCyZe8GXeDvS9ft7R_v9W3TVcCOg8Cd261QM8_VkdYRzLIZuTGWj_pRqOIQnAkwYLGMQB1FWqimELLR0gHCpjEBroJsOR787y1ym3lgybEyvfeh1PygO4LAlOd5obNrpGFnmiZqJ0emabKK-cu7BCxtQW06SbPrHN0_8zVXDGBvndwznittF6K2QdZUcp9sGN2Q0dcGwPrNA_Kzm_uimZJ0_8Ik2iY01XQED13ML106Tig4nrSbYrdugUXQE_oZJotoCvBxDzOAL5BqtJoTSEUiaWc8xWiclrChb2kb6WcmqY_ii2Xa6Q57K89-SE5uhEePSC2BXd8klDWBUTnGEIPIryWFF0UIicOE1C0VehbxSobw2MCiY3eOCc_v-kIIj4r95chGbthoEXv5q2kBC_IP-g7yekmLoN75F-nsnBsdwSGUluBuQwTdVMxTEAyH4K6rWMQI86-lReooKbyokF2qJt5moRsgaBEs5nlOgcAeCWYOnYtFlvHBp9P_IBp9qRC9MkQ6he2AORTVGrAmBAyrUG6i4JbLzvjVSbXIdinM1w_Xl8Og1PCmSiQqXWQczBAEHr5rkceF5F9tMhYJNnzfImHlTFR2tjqSjL_lsOkQaIB_Gzz5-6Tq5E7_-OiQHw6GB1vkbpEe5NmOu01q89lCPQUfdB49yw8-JV9vWtP8Bgw7nw8 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGkRAviPFvgUEtBAIesjaxG6dICPXPqpVBmShDewtJbI9KVVKaVmzfgs_Dp-MucbIGTcDL3qr62th35_NdfPc7Qp6FjqME2F7bUS63ueRtO5KeZ8dca8k6XizyNp0fJt7BMX930jnZIr_KWhhMqyxtYm6oZRrjO_KWwxwXvHuILlrapEUcDUdvF99t7CCFN61lO41CRQ7V-Q8I37I34yHI-rnrjvY_Dw5s02HAjj3PXdldoTlzdaR1BDP2IzfGUtJOJFQswLGAwyyWEZimSIfKD0PZ7moPIdR4CG6D7DoM_vcauS6Y8HGP-YMqvQTsiOeZUj0mnJbRjL1Fmqi9HKXG57WjMO8YUJ0LjcU8zS5zev_M3dw4DEe3yS3jxdJeoXbbZEsld8i2sRMZfWnArF_dJT-HuV-aKUn3z0zSbUJTTafw0PXq3KWzhIITSocpdu4OsSB6To9gsoisAB8HmA18hlTTzfxAGiaS9mcLjMxpCSH6mvaQfmkS_Ci-ZKb94WS08ex75PhKZHSfNBLg-g6h3Gesm-MNcYgCuzJkUYTwODyUuqsEswgrBRLEBiIdO3XMg_zeT0CoVPA3QDEGRowWsatfLQqIkH_Q91HWFS0CfOdfpMvTwNiLAMJqCa43RNO-4kxBYCzAdVdxGCPkv5YWaaKmBEW1bGWmgh4XrocARrCYpzkFgnwkuF1Ow3WWBeOPX_6DaPqpRvTCEOkU2AFzKCo3YE0IHlaj3EHFLZedBRe71iK7pTJfPtyshsHA4a1VmKh0nQVwJEEQ0nEt8qDQ_AsmY8Fgu9OxiKjtiRpn6yPJ7FsOoQ5BB_i63sO_T6pJboCNCd6PJ4ePyM0iU4jZjrtLGqvlWj0Gd3QVPcn3PSVfr9rQ_AbKdaMQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decreased+Expression+of+Sprouty2+in+the+Dorsolateral+Prefrontal+Cortex+in+Schizophrenia+and+Bipolar+Disorder%3A+A+Correlation+with+BDNF+Expression&rft.jtitle=PloS+one&rft.au=Pillai%2C+Anilkumar&rft.date=2008-03-12&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=3&rft.issue=3&rft.spage=e1784&rft_id=info:doi/10.1371%2Fjournal.pone.0001784&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2900684681 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |